Page 1 of Clinical Trials for All Ireland Cooperative Oncology Research Group [SPONSOR-COLLABORATORS], 31 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab), TCL (Docetaxel, Carboplatin and Lapatinib) and the Combination of TCHL (Docetaxel,Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.
Last Updated: December 5, 2011
Condition(s): Breast Cancer
2
Recruiting
This Study Plans to Assess the Response of PAD Treatment to VAD or VAD-Like Treatment in Patients Who Have Relapsed or Refractory Myeloma
Last Updated: December 3, 2007
Condition(s): Multiple Myeloma
3
Recruiting
Radiation Therapy in Treating Patients With Malignant Spinal Cord Compression
Last Updated: March 27, 2012
Condition(s): Spinal Cord Compression; Unspecified Adult Solid Tumor, Protocol Specific
4
Recruiting
Second-line Pazopanib Renal Cell Carcinoma (RCC) Study
Last Updated: March 27, 2012
Condition(s): Renal Cell Carcinoma
5
Recruiting
Radiation Therapy in Treating Patients With Malignant Spinal Cord Compression Who Were Previously Treated With Radiation Therapy
Last Updated: March 27, 2012
Condition(s): Pain; Radiation Toxicity; Spinal Cord Compression; Unspecified Adult Solid Tumor, Protocol Specific
6
Recruiting
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
Last Updated: February 2, 2012
Condition(s): Metastatic Breast Cancer
7
Recruiting
The Myocet/Lapatinib Study
Last Updated: December 19, 2011
Condition(s): Her2 Positive Metastatic Breast Cancer
8
Recruiting
Study of Blood Samples in Predicting How Patients With Prostate Cancer Will Respond to Treatment With Docetaxel
Last Updated: December 6, 2011
Condition(s): Metastatic Cancer; Prostate Cancer
9
Active, not recruiting
Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer
Last Updated: February 11, 2009
Condition(s): Breast Cancer
10
Recruiting
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer
Last Updated: September 9, 2009
Condition(s): Breast Cancer; Colorectal Cancer; Lung Cancer; Melanoma (Skin); Pancreatic Cancer
11
Recruiting
3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer
Last Updated: December 6, 2011
Condition(s): Breast Cancer
12
Recruiting
Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Last Updated: December 6, 2011
Condition(s): Leukemia
13
Recruiting
Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer
Last Updated: August 29, 2009
Condition(s): Pancreatic Cancer
14
Recruiting
Bevacizumab, Docetaxel, and Cyclophosphamide in Treating Patients With Early-Stage High-Risk Breast Cancer
Last Updated: December 6, 2011
Condition(s): Breast Cancer
15
Recruiting
Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Last Updated: December 6, 2011
Condition(s): Lung Cancer; Metastatic Cancer
16
Recruiting
Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Last Updated: July 9, 2010
Condition(s): Lung Cancer
17
Recruiting
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
Last Updated: December 6, 2011
Condition(s): Prostate Cancer
18
Recruiting
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy
Last Updated: December 6, 2011
Condition(s): Prostate Cancer
19
Recruiting
Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer
Last Updated: February 18, 2011
Condition(s): Prostate Cancer
20
Recruiting
Bortezomib, Doxorubicin, and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Not Responded to Treatment
Last Updated: January 7, 2009
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=All+Ireland+Cooperative+Oncology+Research+Group

Page 1 of Clinical Trials for All Ireland Cooperative Oncology Research Group [SPONSOR-COLLABORATORS], 31 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About